NYU Langone Health (NYU Grossman School of Medicine)

NYU Langone Health is a world-class integrated academic health system headquartered in New York City, New York. Its core business encompasses patient care, medical education, and biomedical research. The organization's mission is to "care, to teach, to discover," striving to deliver optimal outcomes in patient care, education, and science.

The health system provides a comprehensive range of services across more than 320 locations in the New York City region and Florida, including seven inpatient facilities. Key offerings include specialized patient care in areas such as brain and spine, cancer, heart health, orthopedics, pediatrics, primary care, and women's health. NYU Grossman School of Medicine, an integral part of NYU Langone Health, offers medical education, including an innovative full-tuition scholarship initiative for all MD students and an accelerated three-year MD program. Additionally, the institution is a hub for scientific research, with numerous academic departments dedicated to advancing medical knowledge.

Alec C. Kimmelman, MD, PhD, assumed the role of Dean of NYU Grossman School of Medicine and CEO of NYU Langone Health in September 2025, succeeding Robert I. Grossman, MD. NYU Langone Health consistently ranks among the top integrated academic health systems nationally, recognized by Vizient as No. 1 for quality care for four consecutive years and holding multiple No. 1 ranked specialties by U.S. News & World Report. All of its hospitals have achieved Magnet® Recognition for nursing excellence. In recent news, NYU Langone announced in February 2026 the discontinuation of its transgender youth health program, citing the "current regulatory environment" and a leadership departure.